Home › Pulmonary Arterial Hypertension › Kansas
Pulmonary Arterial Hypertension clinical trials in Kansas
7 studies for Pulmonary Arterial Hypertension are looking for participants at sites in Kansas.
Cities in Kansas
A Study to Evaluate the Efficacy and Safety of Once Daily Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Arterial Hypertension (PAH)
- USA010, Kansas City
RecruitingPhase 3
Ages 18 to 75 · All sexes · Updated Sep 16, 2026 · NCT07481981An Adaptive Program of IKT-001 in Pulmonary Arterial Hypertension (PAH)
- University of Kansas Medical Center, Kansas City
RecruitingPhase 3
Ages 18 to 75 · All sexes · Updated Sep 2, 2026 · NCT07365332A Study of ROC-101 in Patients With Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated With Interstitial Lung Disease (ILD-PH) (ROCSTAR STUDY)
- The University of Kansas Medical Center Research Institute, Kansas City
RecruitingPhase 2
Ages 18 to 80 · All sexes · Updated Aug 10, 2026 · NCT07175038Open-label Extension Study of Seralutinib in Adult Subjects With PAH (PROSERA-EXT)
- University of Kansas Medical Center, Kansas City
RecruitingPhase 3
Ages 18 to 75 · All sexes · Updated Jul 29, 2026 · NCT06274801A Study to Learn About the Treatment LTP001 in Healthy Participants (Part A) and in Participants With PAH (Part B)
- U of Kansas Medical Center, Kansas City
RecruitingPhase 1/2Healthy volunteers welcome
Ages 18 to 100 · All sexes · Updated Jul 21, 2026 · NCT06649110Pulmonary Hypertension Association Registry
- KU Medical Center, Kansas City
RecruitingObservational study
Ages 0 and older · All sexes · Updated Nov 14, 2025 · NCT04071327Pulmonary Hypertension Biorepository and Registry
- University of Kansas Medical Center, Kansas City
RecruitingObservational study
Ages 18 and older · All sexes · Updated Aug 1, 2025 · NCT04808596From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.